Politico October 21, 2025
THE LAB
An agency within the Department of Health and Human Services has awarded Carnegie Mellon University researchers $26.7 million to develop a single at-home cancer screening system using synthetic biology, which would detect signs of 30 different types of cancer as early as stage one.
Carnegie Mellon’s team is one of four labs to receive award money from the Platform Optimizing SynBio for Early Intervention and Detection in Oncology program within the Advanced Research Projects Agency for Health. ARPA-H will invest $147 million over five years in POSEIDON, according to the agency. The funding award was announced before the government shutdown began.
The agency did not respond to a request for comment.
How it works: The multi-cancer early detection...
Today's Sponsors
Today's Sponsor